PRESENTATION · Apr 2025 · PDF
Science
Explore conditions, clinical trials, and the latest research.
These pages contain non-exhaustive scientific information about uses of products that have not yet been approved by regulatory authorities, as their efficacy and safety for these uses have not yet been established. The information is provided for educational and scientific exchange purposes, and does not suggest products should be used in a manner not consistent with their respective label approved by the regulatory authorities, which may differ by geography. Any publication reflects the state of knowledge at the time it was published. The information is not medical advice and cannot replace the independent medical judgement of a healthcare professional.
PRESENTATION · Apr 2025 · PDF
Acoramidis TTR - ACC 2025 - Pre-specified NT-proBNP Sensitivity Analyses
PRESENTATION · Apr 2025 · PDF
Acoramidis TTR - ACC 2025 - Improvements in NYHA Class at Month 30 Versus Placebo
PRESENTATION · Mar 2025 · PDF
Acoramidis TTR - ACC 2025 -Healthcare Disparities and Diagnostic Trends
PRESENTATION · Mar 2025 · PDF
BBP-418 - MDA 2025 - Understanding the Burden of LGMD2I/R9
PRESENTATION · Mar 2025 · PDF
BBP-418 - MDA 2025 - Baseline Characteristics FORTIFY
PRESENTATION · Dec 2024 · PDF
Infigratinib - ISDS 2024 - Clinical Development Program Update
PRESENTATION · Dec 2024 · PDF